Pharmacovigilance Scientist, Lead PV Operations, Agenus Therapeutics Lexington, Massachusetts, USA, Molecular Biosciences
The University of Nottingham, USA
HIEP (BEN) NGUYEN
Senior scientist, Aurobindo
RIKHAV P GALA
Research Scientist, Department of Pharmaceutical Sciences
Submit manuscript at www.walshmedicalmedia.com/submissions/pharmacovigilance.html or send as an e-mail attachment to the Editorial Office at [email protected]
Index Copernicus Value 2016: 82.05
National Libray of Medicine [NLM ID] :101634347
The purpose of the Journal of Pharmacovigilance (JP) is to publish quality case reports, original research and review articles about the pharmaceutical intervention safety, side effects and adverse effects as well as medications toxicity. Unintended effects are common yet often times there is lack of qualitative and quantitative data that allows for an accurate assessment of the risk/benefits profile of pharmaceuticals. The Journal of Pharmacovigilance aims to fill this important knowledge gap.
Journal of Pharmacovigilance is an Open Access journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide. The Journal of Pharmacovigilance is an open access peer-reviewed journal. Our full open-access policy, which makes all published material immediately available to the public and it is especially relevant when it comes to information about drugs safety and toxicity.
The Pharmacovigilance Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Pharmacovigilance journal impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Pharmacovigilance Open Access Journal are freely accessible to everyone immediately after publication.
Fast Editorial Execution and Review Process (FEE-Review Process):
Journal of Pharmacovigilance is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in Journal of Pharmacovigilance have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacovigilance has got h-index 21 , which means every article in Journal of Pharmacovigilance has got 21 average citations.